GLP-1 clinical trials in Oklahoma: 12 recruiting now
14 sites in 4 Oklahoma cities. Registry checked October 16, 2026.
Screening for a study can take weeks. Two cash programs to check.
No insurance needed.
- SnagRxSponsored$99 a monthcompounded semaglutideCheck price →SnagRx's homepage shows its 12-month prepaid prices first
- MedviSponsored$299 a monthFirst month $179compounded semaglutideCheck price →Straight to MEDVi's GLP-1 sign-up
Weight-loss studies (5)
Weight-loss study of cagrisema
Where: Norman
What: Tests whether a study medicine from Novo Nordisk, cagrisema, can help people with type 2 diabetes lose weight.
Free to join
Who can join: Adults 18+ with obesity, BMI 35+.
Study record on ClinicalTrials.gov
Alliance for Multispecialty Research, Norman
Lynn Institute of Norman, Norman
Weight-loss study of maridebart cafraglutide
Where: Chickasha and Oklahoma City
What: Tests whether a study medicine from Amgen, Maridebart Cafraglutide, can help people lose weight.
Free to join
Who can join: Adults 18+ with obesity or overweight, BMI 25+.
Study record on ClinicalTrials.gov
Epic Medical Research - Oklahoma, Chickasha
Lynn Health Science Institute, Oklahoma City
Weight-loss study of orforglipron
Where: Oklahoma City
What: Tests whether a GLP-1 medicine from Lilly, orforglipron, can help people lose weight.
Free to join
Who can join: Children and teens 6 to 17 with obesity.
Study record on ClinicalTrials.gov
University of Oklahoma Health Sciences Center, Oklahoma City
Show 2 more studies
Weight-loss study of cagrilintide
Where: Oklahoma City
What: Tests whether a study medicine from Novo Nordisk, cagrilintide, can help people lose weight.
Free to join
Who can join: Children and teens 8 to 18 who are overweight.
Study record on ClinicalTrials.gov
Children's Physicians OU, Oklahoma City
Weight-loss study of tirzepatide
Where: Oklahoma City
What: Tests whether a GLP-1 and GIP medicine from Lilly, tirzepatide, can help people lose weight.
Free to join
Who can join: Children and teens 6 to 11 with obesity.
Study record on ClinicalTrials.gov
Oklahoma Childrens Memorial Hospital, Oklahoma City
Type 2 diabetes studies (3)
Type 2 diabetes study of semaglutide
Where: Oklahoma City
What: Tests whether a GLP-1 medicine, semaglutide, can help people with type 2 diabetes lower blood sugar.
Free to join
Who can join: Adults 18+ with type 2 diabetes, BMI 23+.
Study record on ClinicalTrials.gov
Research Site, Oklahoma City
Type 2 diabetes study of survodutide
Where: Oklahoma City
What: Tests whether a GLP-1 and glucagon medicine from Boehringer Ingelheim, survodutide, can help people with type 2 diabetes lower blood sugar.
Free to join
Who can join: Adults 18+ with type 2 diabetes, BMI 23+.
Call the site: 833-602-2368Study record on ClinicalTrials.gov
Tekton Research Oklahoma City, Oklahoma City. 833-602-2368
Type 2 diabetes study of LY3457263
Where: Norman
What: Tests whether an investigational medicine from Lilly, LY3457263, can help people with type 2 diabetes lower blood sugar.
Free to join
Who can join: Adults 18 to 75 with type 2 diabetes, BMI 27+.
Call the site: 405-701-8999Study record on ClinicalTrials.gov
Alliance for Multispecialty Research, LLC, Norman. 405-701-8999
Other GLP-1 studies in Oklahoma (4)
Fatty liver disease with liver scarring study of survodutide
Where: Tulsa
What: Tests whether a GLP-1 and glucagon medicine from Boehringer Ingelheim, survodutide, can help people reduce liver fat.
Free to join
Who can join: Adults 18+ with fatty liver disease (also called MASH or NASH) with liver scarring (fibrosis).
Call the site: 833-602-2368Study record on ClinicalTrials.gov
Options Health Research, Tulsa. 833-602-2368
Fatty liver disease (also called MASH or NASH) study of survodutide
Where: Tulsa
What: Tests whether a GLP-1 and glucagon medicine from Boehringer Ingelheim, survodutide, can help people reduce liver fat.
Free to join
Who can join: Adults 18+ with fatty liver disease (also called MASH or NASH), BMI 25+.
Call the site: 833-602-2368Study record on ClinicalTrials.gov
Options Health Research, Tulsa. 833-602-2368
Prehypertension study of orforglipron
Where: Tulsa
What: Tests whether a GLP-1 medicine from Lilly, orforglipron, can help people with prediabetes lose weight.
Free to join
Who can join: Adults 18+ who are overweight, BMI 25+.
Call the site: 918-645-5400Study record on ClinicalTrials.gov
Central States Research, Tulsa. 918-645-5400
Show 1 more study
Tobacco use study of semaglutide
Where: Oklahoma City
What: Tests a GLP-1 medicine, semaglutide, in people trying to quit smoking.
Free to join
Who can join: Adults 18 to 65 who are trying to quit smoking, BMI 30+.
Call the site: 405-271-7759Study record on ClinicalTrials.gov
Health Promotion Research Center, Oklahoma City. 405-271-7759
Source: ClinicalTrials.gov, the federal registry, read October 16, 2026. Open a study's registry record before you call: it can close to new participants at any time. GLP Chart does not enroll anyone, is not paid for clinical-trial referrals and has no relationship with any sponsor or site on this page.
Clinical trials by state
Every state with a GLP-1 study recruiting today. 48 of them.
- Alabama (18)
- Arizona (22)
- Arkansas (5)
- California (53)
- Colorado (18)
- Connecticut (14)
- Delaware (1)
- District of Columbia (1)
- Florida (43)
- Georgia (23)
- Hawaii (6)
- Idaho (12)
- Illinois (30)
- Indiana (20)
- Iowa (10)
- Kansas (14)
- Kentucky (18)
- Louisiana (14)
- Maine (1)
- Maryland (25)
- Massachusetts (20)
- Michigan (21)
- Minnesota (19)
- Mississippi (7)
- Missouri (22)
- Montana (3)
- Nebraska (7)
- Nevada (11)
- New Hampshire (3)
- New Jersey (11)
- New Mexico (5)
- New York (30)
- North Carolina (31)
- North Dakota (5)
- Ohio (31)
- Oklahoma (12)
- Oregon (5)
- Pennsylvania (33)
- Rhode Island (5)
- South Carolina (25)
- South Dakota (2)
- Tennessee (27)
- Texas (56)
- Utah (14)
- Virginia (28)
- Washington (24)
- West Virginia (5)
- Wisconsin (7)